Cargando…
Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
In recent years, adoptive cell therapy has gained a new perspective of application due to the development of technologies and the successful clinical use of CAR-T cells for the treatment of patients with malignant B-cell neoplasms. However, the efficacy of CAR-T therapy against solid tumor remains a...
Autores principales: | Valiullina, Aigul Kh., Zmievskaya, Ekaterina A., Ganeeva, Irina A., Zhuravleva, Margarita N., Garanina, Ekaterina E., Rizvanov, Albert A., Petukhov, Alexey V., Bulatov, Emil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953664/ https://www.ncbi.nlm.nih.gov/pubmed/36831162 http://dx.doi.org/10.3390/biomedicines11020626 |
Ejemplares similares
-
Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line
por: Valiullina, Aigul Kh., et al.
Publicado: (2023) -
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
por: Zmievskaya, Ekaterina, et al.
Publicado: (2021) -
Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021) -
Knowns and Unknowns about CAR-T Cell Dysfunction
por: Titov, Aleksei, et al.
Publicado: (2022) -
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
por: Titov, Aleksei, et al.
Publicado: (2020)